|
2021
|
Invention
|
Targeted conjugates comprising modified sirna. The invention provides certain nucleic acids (e.g.... |
|
|
Invention
|
Synthesis of substituted arylmethylureas, analogues, and crystalline forms thereof and methods of... |
|
|
Invention
|
Substituted 1,1'-biphenyl compounds and methods using same. The present invention includes substi... |
|
2020
|
Invention
|
Substituted bicyclic and tricyclic ureas and amides, analogues thereof, and methods using same. T... |
|
|
Invention
|
Synthetic processes and intermediates. The invention provides synthetic processes and synthetic i... |
|
|
Invention
|
Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same.... |
|
|
Invention
|
Substituted cyclopropyl-2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same. ... |
|
|
Invention
|
Substituted polycyclic carboxylic acids, analogues thereof, and methods using same. The present i... |
|
2019
|
Invention
|
Substituted arylmethylureas and heteroarylmethylureas, analogues thereof, and methods using same.... |
|
|
Invention
|
Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same. The present ... |
|
|
Invention
|
Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same. The present inven... |
|
|
Invention
|
Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same. hh]quinoli... |
|
2018
|
Invention
|
Novel antiviral agents against hbv infection.
The present invention is directed toward novel com... |
|
2014
|
Invention
|
Inhibitors of secretion of hepatitis b virus antigens. Pharmaceutical compositions of the inventi... |
|
2013
|
Invention
|
Antiviral agents against hbv infection. The present invention provides novel compounds of formula... |
|
|
Invention
|
Novel antiviral agents against hbv infection. The present invention is directed toward novel comp... |
